Literature DB >> 28521198

Clinical characteristics and risk factors of diabetic peripheral neuropathy of type 1 diabetes mellitus patients.

Xia Zhang1, Chen Fang2, Xiang Li1, Yong-Jun Cao1, Qi-Lin Zhang1, Hong-Hong Zhang2, Yun Huang2, Ji Hu3, Chun-Feng Liu4.   

Abstract

BACKGROUND: Small nerve fibers are more easily injured than large ones for diabetic peripheral neuropathy (DPN). The study investigated the characteristics and related risk factors of DPN of T1DM patients using nerve conduction velocity and CPT values, which provided evidences for its early diagnosis.
METHODS: 70 T1DM patients and 48 healthy volunteers were included. All subjects accepted nerve conduction velocity and CPT examinations for four limbs. Detailed clinical indicators were recorded. CPT values were compared between TIDM group and control group. The risk factors affecting DPN were further explored.
RESULTS: Compared with the control group, CPT values under three frequencies were decreased in T1DM group. The abnormality rate of sural nerves was higher than that of median nerves (P<0.001). Median nerve dysfunction mainly presented as hypoesthesia under 250Hz and 5Hz current stimulus. And sural nerve dysfunction mainly presented as hyperesthesia under three frequencies. Compared with left median nerve, abnormal rate of right median nerve was higher under 2000Hz current stimulus (P=0.035). However, abnormal rate of left sural nerve was higher than that of right side under 250Hz and 5Hz current stimulus (P=0.001, <0.001). Duration, NDS scores and CPT values of right median nerve under 2000Hz current stimulus were independent risk factors of abnormal nerve conduction velocity.
CONCLUSIONS: The study proved that DPN of T1DM are mainly lower limb-injured., amyelinated and thin myelinated nerve fiber-involved. CPT can be combined with traditional nerve conduction velocity examination, which will help the diagnosis of DPN of T1DM earlier and more comprehensively.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Current perception threshold; Diabetic peripheral neuropathy; Nerve conduction velocity; Type 1 diabetes mellitus

Mesh:

Year:  2017        PMID: 28521198     DOI: 10.1016/j.diabres.2017.04.016

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  7 in total

Review 1.  Type 1 Diabetes Mellitus in Saudi Arabia: A Soaring Epidemic.

Authors:  Asirvatham Alwin Robert; Abdulrahman Al-Dawish; Muhammad Mujammami; Mohamed Abdulaziz Al Dawish
Journal:  Int J Pediatr       Date:  2018-05-08

Review 2.  Fasudil combined with methylcobalamin or lipoic acid can improve the nerve conduction velocity in patients with diabetic peripheral neuropathy: A meta-analysis.

Authors:  De-Qi Jiang; Lan-Cheng Xu; Li-Lin Jiang; Ming-Xing Li; Yong Wang
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

3.  Trigeminal nociceptive function and oral somatosensory functional and structural assessment in patients with diabetic peripheral neuropathy.

Authors:  Y M Costa; P Karlsson; L R Bonjardim; P C R Conti; H Tankisi; T S Jensen; J R Nyengaard; P Svensson; L Baad-Hansen
Journal:  Sci Rep       Date:  2019-01-17       Impact factor: 4.379

4.  Lower body mass index is not of more benefit for diabetic complications.

Authors:  Yongze Zhang; Yangyang Guo; Ximei Shen; Fengying Zhao; Sunjie Yan
Journal:  J Diabetes Investig       Date:  2019-02-05       Impact factor: 4.232

5.  Clinical significance of apelin in the treatment of type 2 diabetic peripheral neuropathy.

Authors:  Hua Xu; Qi Wang; Qian Wang; Xuan Qiang Che; Xue Liu; Shumiao Zhao; Shitao Wang
Journal:  Medicine (Baltimore)       Date:  2021-04-30       Impact factor: 1.817

6.  Abnormalities of the oculomotor function in type 1 diabetes and diabetic neuropathy.

Authors:  Francesca D'Addio; Ida Pastore; Cristian Loretelli; Alessandro Valderrama-Vasquez; Vera Usuelli; Emma Assi; Chiara Mameli; Maddalena Macedoni; Anna Maestroni; Antonio Rossi; Maria Elena Lunati; Paola Silvia Morpurgo; Alessandra Gandolfi; Laura Montefusco; Andrea Mario Bolla; Moufida Ben Nasr; Stefania Di Maggio; Lisa Melzi; Giovanni Staurenghi; Antonio Secchi; Stefania Bianchi Marzoli; Gianvincenzo Zuccotti; Paolo Fiorina
Journal:  Acta Diabetol       Date:  2022-06-22       Impact factor: 4.087

Review 7.  Redefining distal symmetrical polyneuropathy features in type 1 diabetes: a systematic review.

Authors:  Eleonora Galosi; Xiaoli Hu; Nivatha Michael; Jens Randel Nyengaard; Andrea Truini; Páll Karlsson
Journal:  Acta Diabetol       Date:  2021-07-02       Impact factor: 4.280

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.